Growth assessment in patients with attention-deficit/hyperactivity disorder (Study TEIDE)
DEC-NET Serial number ES585
Published online13/06/2006 11.47.00
Last updated30/06/2006 13.30.59
Other protocol ID numberJAN-MET-2004-02
Current trial statusTerminated (withdrawn)
Major Disease
(ICD9 class)
ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPER
GenderBoth
Age (range)6-14 years

Eligibility criteria
Inclusion criteria
Patients 5 to 14 years old with DSM-IV criteria of ADHD.
Exclusion criteria
- Patients with no information in the medical record. - Continuous follow-up impossible during the study period (two years).

Trial design/methodology
Phase
Kind of study
DesignControlled
Estudio farmaco-epidemiológico
Purpose of study
To assess growth in patients with attention-deficit/hyperactivity disorder (ADHD); 2 years follow up of a cohort of patients.
Primary outcomes
Standard deviation of height and weigh.
Secondary outcomes
- Demographic data - Course of the disease - Actual treatment - Previous stops of treatment - Weigh and height of parents - SF12 of quality of life
Summary of study design, objectives, and ongoing research findings
The study has been terminated because there are no patients included.
Principal investigator
NameDr. José Angel Alda
InstitutionHospital Sant Joan de Déu (Barcelona)
Postal addressPasseig St. Joan de Déu nº 2
CityBarcelona
CountrySPAIN
Phone93 280 40 00
Fax
E-mailjalda@hsjdbcn.org


Promoter
Janssen Cilag S.A. (Industry)

ISRCTN  EudraCT